𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases

✍ Scribed by Jeffrey I. Cohen

Book ID
117211337
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
92 KB
Volume
40
Category
Article
ISSN
1532-8686

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo models for Epstein–Barr virus (E
In vivo models for Epstein–Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD)
✍ I. Johannessen; D. H. Crawford 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

EBV infects B lymphocytes in vivo and establishes a life-long persistent infection in the host. The latent infection is controlled by EBV-specific MHC class 1-restricted CTL. Immunosuppression reduces CTL activity, and this facilitates outgrowth of EBV+ve B cell lymphoproliferative disease (BLPD). B

Molecular markers of clonality and ident
Molecular markers of clonality and identity in epstein–barr virus-associated B-cell lymphoproliferative disease
✍ Dennis M. Walling; Leslie A. Andritsos; Wiguins Etienne; Deborah A. Payne; Judit 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

## Abstract Epstein–Barr virus (EBV)‐associated B‐cell lymphoproliferative disease may be polyclonal, oligoclonal, or monoclonal. The degree of tumor clonality reflects the disease pathogenesis and may have implications for disease diagnosis, prognosis, and treatment. In this study, specimens of EB